Search by Drug Name or NDC
NDC 00276-0509-30 Mefenamic Acid 250 mg/1 Details
Mefenamic Acid 250 mg/1
Mefenamic Acid is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Misemer Pharmaceuticals, Inc. The primary component is MEFENAMIC ACID.
MedlinePlus Drug Summary
Mefenamic acid is used to relieve mild to moderate pain, including menstrual pain (pain that happens before or during a menstrual period). Mefenamic acid is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
Related Packages: 00276-0509-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mefenamic Acid
Product Information
NDC | 00276-0509 |
---|---|
Product ID | 0276-0509_d0291319-ab22-20c8-e053-2a95a90afabb |
Associated GPIs | 66100050000105 |
GCN Sequence Number | 004285 |
GCN Sequence Number Description | mefenamic acid CAPSULE 250 MG ORAL |
HIC3 | S2B |
HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
GCN | 16530 |
HICL Sequence Number | 001776 |
HICL Sequence Number Description | MEFENAMIC ACID |
Brand/Generic | Generic |
Proprietary Name | Mefenamic Acid |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Mefenamic Acid |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | MEFENAMIC ACID |
Labeler Name | Misemer Pharmaceuticals, Inc |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA091608 |
Listing Certified Through | 2022-12-31 |
Package
NDC 00276-0509-30 (00276050930)
NDC Package Code | 0276-0509-30 |
---|---|
Billing NDC | 00276050930 |
Package | 30 CAPSULE in 1 BOTTLE (0276-0509-30) |
Marketing Start Date | 2021-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |